Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 248

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 248
---
                                
 action, assessment or investigation that is material to the Company and involving the Company or its Subsidiary or material asset of either; |

| (T) | not waive, release, grant, transfer, exercise, modify or amend in any material respect, other than in                                                                                                                                    
 connection with the Discontinuance, (1) any existing contractual rights in respect of any joint ventures of the Company, (2) any Authorization, lease, concession, contract or other document, or (3) any other material legal rights or 
 claims;                                                                                                                                                                                                                                  |

| (U) | not propose or enter into any agreement, arrangement, commitment, or offer with respect to a material joint 
 venture or other mutual co-operation or distribution agreement;                                             |

| (V) | not enter into any interest rate, currency or equity swaps, hedges, derivatives or other similar financial                                                                                 
 instruments other than (1) in connection with the Discontinuance, (2) if approved by the Board of Directors prior to the date hereof or (3) if required under existing banking facilities; |

| (W) | not increase any coverage under any directors’ and officers’ insurance policy other than as 
 contemplated in Section 5.8;                                                                |

| (X) | not acquire or agree to acquire (by merger, amalgamation, arrangement, acquisition of stock or assets or                                                                                                                                                 
 otherwise) any person or division of any person or make any investment either by purchase of shares or securities, contributions of capital (other than to the Subsidiary), property transfer or purchase of any property or assets of any other person; |

| (Y) | except in connection with the Discontinuance, not adopt a plan of complete or partial liquidation, arrangement,                                                                                                                                      
 dissolution, amalgamation, merger, consolidation, restructuring, recapitalization, winding-up or other reorganization of the Company or the Subsidiary (other than this Agreement and the Contemplated                                               
 Transactions), or file a petition in bankruptcy under any applicable Law on behalf of the Company or the Subsidiary, or consent to the filing of any bankruptcy petition against the Company or the Subsidiary under any applicable Law; for further 
 certainty, nothing in this Agreement shall limit the ability of the Company to liquidate, wind-up and/or dissolve the Subsidiary during the Interim Period;                                                                                          |

| (AA) | not (1) make, change or revoke any material Tax election, (2)